Biohaven Pharmaceutical Holding (BHVN) PT Raised to $144 at Mizuho Securities Following Review of Ex-Pfizer Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NYSE: BHVN) | Delayed: 15.21 -0.4 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.61 | 52 Week High | $ | |||
| Open | $15.97 | 52 Week Low | $ | |||
| Day High | $16.15 | P/E | N/A | |||
| Day Low | $15.12 | EPS | $ | |||
| Volume | 971,014 | |||||
